It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

Many of those terminated worked on issues critical to consumers, from improving health care to regulating food packaging to ...

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

After a mid-air crash in January between a passenger plane and a U.S. military Black Hawk helicopter over Reagan ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

The results showed that people who took sotagliflozin had a 23% lower risk of heart attacks, strokes, and death from ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval ...

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

Scientists at the University of Cambridge have made 'smart pyjamas', utilising sensors trained with artificial intelligence, ...